Back to
Resona Asset Management Co., Ltd.
ALNY
Showing 8 of 10 quarters
Position history for
Resona Asset Management Co., Ltd.'s holdings in Alnylam Pharmaceuticals, Inc.
Yes. Resona Asset Management holds 40,053 shares of ALNY (Alnylam Pharmaceuticals), worth $12M, as of its Q2 2026 13F filing. It increased the position by 221 shares (+0.6%) from Q1 2026. Resona Asset Management has held ALNY in every 13F on record since Q1 2024, 10 quarterly filings. ALNY is 0.1% of Resona Asset Management's reported 13F portfolio.
Current Value
$12M
Current Shares
40,053
Total Value Change
+$1.7M
Total Shares Change
+2,476
Quarter-by-Quarter History